AlphaMadera's AlphaVal page computes Sabra Health Care REIT, Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag SBRA as undervalued, fairly valued, or overvalued.

What is Sabra Health Care REIT, Inc.'s fair value?

Fair value for SBRA is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value SBRA?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from SBRA's most recent reported fundamentals.

SBRA - Sabra Health Care REIT, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $21.80 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Real Estate Investment Trust 85% confidence

Primary model: P/FFO × Healthcare REIT Multiple

Valuation Signal Fair Value Mild

Trading 12.9% below fair value

Current Price $20.72

Bear Case $18.50 10.7% downside ($18.50 - $20.72) / $20.72 = -10.7% $1.36 FFO × 14x

Fair Value $23.79 14.8% upside ($23.79 - $20.72) / $20.72 = 14.8% $1.36 FFO × 18x

Bull Case $29.08 40.3% upside ($29.08 - $20.72) / $20.72 = 40.3% $1.36 FFO × 22x

Adjust Assumptions

P/FFO Multiple

18.0x

FFO per Share

1.36$

Key Value Driver

FFO/share ($1.36) × healthcare P/FFO multiple

Implied Market Multiple 15.3x

Plain-Language Summary

Our base-case estimate uses P/FFO × Healthcare REIT Multiple. We then blend that result with the average analyst price target of $21.80 from 29 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $23.79 per share.

Warnings

⚠ Standard profit figures are misleading for real estate companies — large non-cash accounting charges make profits look artificially low. Dividend yield and funds from operations are better measures.

⚠ Dividend yield of 5.8% is unusually high — make sure the company generates enough cash to keep paying it.

Key Risks

P/E and EV/EBITDA are structurally wrong for REITs — use P/FFO and NAV
Interest rate sensitivity: REIT multiples compress when rates rise
FFO approximation (NI + D&A) may include gains on property sales — verify